Truist Securities Maintains Buy on CG Oncology, Raises Price Target to $85

Benzinga · 2d ago
Truist Securities analyst Gregory Renza maintains CG Oncology (NASDAQ:CGON) with a Buy and raises the price target from $82 to $85.